Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Immunotherapy for NSCLC: Recent advances and future directions

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.01.20
Views: 130
Rating:

Prof Neal Ready - Duke University School of Medicine, Durham, USA

Prof Neal Ready speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the different immunotherapies available to treat non-small-cell lung cancer (NSCLC).

He describes the recent advances in this area, including the selection of patients, based on their PDL-1 expression for example.

Prof Ready highlights the different types of therapy available for these patients and describes what the future looks like in this field.

 

Related videos

follow us

SIOG metastatic renal cell carcinoma


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation